Status:
UNKNOWN
Sarcopenia and Outcomes of Neuroplasty in Lumbar Spinal Stenosis
Lead Sponsor:
Asan Medical Center
Conditions:
Lumbar Spinal Stenosis
Neurogenic Claudication
Eligibility:
All Genders
65-79 years
Brief Summary
The aim of the present study is to find out the influence of sarcopenia on outcomes of neuroplasty in patients with lumbar spinal stenosis.
Detailed Description
Frailty is an aging-related syndrome of physiological decline and correlated with sarcopenia. Furthermore, lumbar spinal stenosis is a common disease in the old population and a neuroplasty is widely ...
Eligibility Criteria
Inclusion
- Presence of lumbar spinal stenosis on MRI
- 65 ≤ age \<79
- Neurogenic claudication due to spinal stenosis
- Chronic pain above than 3 months despite conservative therapies
- Scheduled for neuroplasty with Racz catheter
Exclusion
- Allergy to local anesthetics, contrast dye, or steroid
- Use of anticoagulants or antiplatelet medication
- Coagulopathy or Infection at the insertion site
- Neurological or psychiatric disorders
- Hemodynamic instability due to other underlying disorders
- Prior spine instrumentation
- Vascular claudication
- Refusal to participate in the study
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04374669
Start Date
May 20 2020
End Date
April 30 2023
Last Update
December 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan medical center
Seoul, South Korea, 05505